Comments
Commented by Fabian Lorenz on June 26th, 2025 | 07:35 CEST
Sensational news drives shares: RENK, BYD, and Desert Gold
A major announcement from Desert Gold: the gold explorer has secured another exciting project. In an interview, the CEO expressed strong optimism. The new asset offers synergies with the Company's existing mega-project, which is nearing a PEA. The goal is to become a gold producer by 2026 - significantly increasing the likelihood of a takeover. RENK & Co. benefited yesterday from the NATO meeting and a cheerful Donald Trump. The confirmation of the 5% target for defense spending caused defense stocks to rise. In contrast, BYD shares remain weak. The Chinese are rushing from one sales record to another – or were they rushing? Because they seem to be falling victim to their own strategy. Investors are fleeing.
Read
Commented by Armin Schulz on June 26th, 2025 | 07:15 CEST
NATO's 5% target: Why Almonty Industries' mega mine and NASDAQ listing are a perfect fit for investors
Geopolitical conflicts and trade restrictions are making it increasingly difficult to source critical raw materials. Western companies in the high-tech and defense sectors are particularly struggling with scarce supplies and increasingly stringent export controls. With NATO's new 5% defense spending target, the battle for raw materials such as tungsten, which are essential for defense equipment, is set to gain further momentum. As a result, the demand for independent suppliers and the need for reliable partners with sufficient capacity is growing. Almonty Industries has already established a unique profile as a tungsten producer, with assets ranging from mines in Europe to the upcoming commissioning of a mega deposit in South Korea.
Read
Commented by Nico Popp on June 26th, 2025 | 07:05 CEST
Decoding the Code of Life – What comes next? Illumina, PanGenomic Health, Moderna
Genetic information is the blueprint of life. Even today, genome sequencing enables us to gain insights that can extend our lives. This is especially true when we can identify certain predispositions to diseases in advance and respond with a healthy lifestyle. Numerous business models are currently emerging around this technology. Some of these are very capital-intensive. Others leverage existing research and artificial intelligence, making them incredibly smart opportunities for investors.
We provide an overview.
Commented by André Will-Laudien on June 26th, 2025 | 07:00 CEST
New biotech boom ignites: Are Evotec, BioNxt, Bayer, Novo Nordisk, and Formycon poised for the next price surge?
The biotechnology industry is currently experiencing a remarkable renaissance. Innovations in personalized medicine, advances in mRNA technologies, and new therapeutic approaches to cancer and autoimmune diseases are fueling investor interest worldwide. In this dynamic environment, established players such as Evotec and Bayer, as well as specialized up-and-comers like BioNxt and Formycon, are moving into the spotlight of strategic investments. While Evotec scores with its strong partner network, Bayer is working on a realignment with a focus on promising research. BioNxt impresses with a lean business model and promising pipeline products in the field of drug delivery. Formycon, on the other hand, is benefiting from the biosimilar boom and is currently undergoing a turnaround. The industry is highly innovation-driven, and those who bet on the right players could reap above-average rewards.
Read
Commented by Fabian Lorenz on June 25th, 2025 | 07:30 CEST
BioNTech swallows CureVac! Evotec and Vidac Pharma next? Price driver takeover and Buy recommendation
Is Vidac Pharma about to see another price explosion? Last fall, the share rose by around 200%. Yesterday, there was a "Buy" recommendation. Analysts see potential for growth in this biotech gem. The latest news on the drug candidate VDA 1102 for brain tumors is promising. Could a takeover be on the cards? CureVac's share price has nearly doubled since the beginning of April. BioNTech plans to acquire its mRNA competitor and thus end patent disputes. Evotec is a permanent fixture on the takeover merry-go-round. However, this currently seems to be the only hope for rising share prices. The management's new strategy has not created the hoped-for wave of optimism. Is it still worth buying now?
Read
Commented by Nico Popp on June 25th, 2025 | 07:15 CEST
New trends in aerospace are driving growth: Volatus Aerospace, Lockheed Martin, Boeing
The new global security situation shows that military potential can secure peace. Even if staunch pacifists proclaim the opposite, the latest measures taken by Israel and the US against Iran have demonstrated that decisive action pays off – the mullah state's nuclear program appears to have been significantly delayed, at the very least. Military innovations have been particularly significant in the aerospace sector in recent years. However, many formerly purely military approaches are also proving their worth in civilian applications. We take a look at Lockheed Martin, Boeing, and Volatus Aerospace, highlight their innovations, and venture a look at how their shares are likely to perform.
Read
Commented by André Will-Laudien on June 25th, 2025 | 07:10 CEST
Geopolitical wild card: Almonty on track for another price surge, overtaking Rheinmetall, Hensoldt, and RENK
Almonty Industries (TSX: AII; WKN: A1JSSD; ISIN: CA0203981034; CAD 3.23) remains in the spotlight, and rightly so! The tungsten resource stock has been one of the absolute top performers so far in 2025 and has the potential to move into a completely new league. All signs point to a revaluation. What is developing here is more than just a mining project; it is a geopolitically highly relevant raw materials offensive with billion-dollar potential. Amid escalating trade conflicts, China is sending a strategic counter-signal and restricting exports of key metals. Tungsten is thus becoming a critical element for high-tech, aviation, and defense and is now at the top of governments' procurement lists. This is precisely where Almonty comes in. With the Sangdong mine in South Korea, the largest Western tungsten supplier outside China will be established by 2025. US defense companies are already securing the coveted resources – long-term, exclusively, and strategically. The confidence is huge, and the timing is perfect. Those who get in now could ride the next wave of growth. A surge in valuation is more than just likely; it is inevitable!
Read
Commented by Nico Popp on June 25th, 2025 | 07:05 CEST
The economy is becoming sustainable – and the stock market is delighted: dynaCERT, Siemens, Shell
ESG criteria have become established across all industries. The prevailing principle in today's business world is that even producers of fossil energy must take action to become more sustainable. This principle is known as "Best-in-Class" and ensures that every industry makes the most of its opportunities to move toward greater sustainability. We present three exciting sustainable business models - Shell, Siemens, and dynaCERT - and explain where opportunities may lie for investors.
Read
Commented by Armin Schulz on June 25th, 2025 | 07:00 CEST
US hydrogen industry under pressure: Plug Power struggles - Things are looking much better for First Hydrogen and thyssenkrupp nucera
While Europe is hitting the hydrogen accelerator, as evidenced by more than 100 events during Hydrogen Week 2025 and billions being invested in infrastructure and electrolyzer factories, the US market is stumbling. Political U-turns are abruptly halting subsidies and jeopardizing projects, especially those involving green hydrogen. However, the global megatrend remains intact. Europe is pushing ahead with decarbonization, aiming to double its production capacity by 2030, and the market is growing dynamically. In this field of tension between setbacks and new beginnings, we take a look at three key players: Plug Power, First Hydrogen, and thyssenkrupp nucera.
Read
Commented by Nico Popp on June 24th, 2025 | 07:40 CEST
Hydrogen – The new trends: Plug Power, Pure Hydrogen, thyssenkrupp
German industry is set to go green. But once again, reality is proving more complex. In March, Thyssenkrupp withdrew a hydrogen tender because all submitted bids significantly exceeded the assumed cost conditions for hydrogen. So, is the hydrogen hype failing to take hold in the real economy? We take a closer look at the latest developments and explain which companies are now in pole position.
Read